Cite
HARVARD Citation
Sharp, C. et al. (n.d.). S8 Rituximab Therapy For Refractory Myositis Related Interstitial Lung Disease Unresponsive To Conventional Immunosuppression: The Bristol Interstitial Lung Disease Service Experience. Thorax. p. A7. [Online].